Skip to main content
SpringerLink
Log in

Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectively in the mesolimbic dopaminergic system

  • Original Article
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Abstract

The atypical profile of clozapine and some other new atypical antipsychotic drugs has been attributed to a relatively selective effect on the mesolimbic dopaminergic system, as well as to their potent serotonin 5-HT2 receptor antagonism and high ratio of 5-HT2 to dopamine D2 receptor affinities. It is unclear, however, how concurrent 5-HT2 and D2 receptor antagonism specifically affects the mesoaccumbens and the mesocortical dopaminergic systems.

The present study examined the effect of pretreatment with the 5-HT2 receptor antagonist, ritanserin, on changes in midbrain dopamine neuronal activity as well as in forebrain, extracellular concentrations of dopamine, induced by relatively low doses of the D2 receptor antagonist raclopride, utilizing in vivo extracellular single cell recording techniques and voltammetry in anesthetized rats, as well as microdialysis in freely moving rats. Raclopride alone (10–2560 μg/kg, i.v.) induced a dose-dependent increase in three parameters of neuronal activity, i.e. burst firing, firing rate and variation coefficient, of midbrain DA neurons. This effect of raclopride was more pronounced in cells of the ventral tegmental area than in cells of the substantia nigra-zona compacta. Ritanserin alone (1.0 mg/kg, i.v.) also increased all three parameters of neuronal activity in dopamine cells of the ventral tegmental area, but only firing rate in the cells of the substantia nigra. Ritanserin pretreatment (30 min) significantly enhanced the stimulatory effects of low doses of raclopride (10–20 μg/kg) on burst firing in dopamine neurons, preferentially in the ventral tegmental area. Raclopride alone (50 μg/kg, s.c.) increased extracellular concentrations of dopamine in the medial prefrontal cortex and the dorsolateral striatum by 75 and 110%, respectively, as measured by microdialysis. Ritanserin alone (1.5 mg/kg, s.c.) did not significantly affect cortical and striatal extracellular dopamine concentrations; however, pretreatment (40 min) with ritanserin elevated the raclopride-induced increase of dopamine concentrations in the medial prefrontal cortex to about 250%, but failed to affect the action of raclopride on striatal dopamine levels. Raclopride alone (10 and 320 μg/kg, i.v.) dose-dependently increased extracellular concentrations of dopamine in the nucleus accumbens and the dorsolateral striatum to about 500%, as determined by voltammetry. Ritanserin alone (1.0 mg/kg, i.v.) did not significantly affect the voltammetric dopamine signal in the nucleus accumbens or the dorsolateral striatum; however, ritanserin pretreatment (30 min) enhanced the raclopride-induced increase in accumbal but not striatal dopamine concentrations to about 1600%. The stimulatory effect of the combined ritanserin plus raclopride treatment on neuronal activity and DA release was more pronounced in the mesolimbic than the nigrostriatal dopaminergic system.

The present data indicate that concurrent 5-HT2 and D2 receptor antagonism selectively affects the activity of the mesolimbic dopaminergic system. These findings provide an experimental basis for the notion that combined 5-HT2 and D2 receptor antagonism may underlie the limbic mode of action of at least some atypical antipsychotic drugs and consequently contribute to their unique therapeutic effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Altar CA, Wasley AM, Neale RF, Stone GE (1986) Typical and atypical antipsychotic occupancy of D2 and S2 receptors: an auto radiographic analysis in rat brain. Brain Res Bull 16:517–525

    Google Scholar 

  • Andén NE, Stock G (1973) Effects of clozapine on the turnover of dopamine in the corpus striatum and in the limbic system. J Pharm Pharmacol 25:346–348

    Google Scholar 

  • Andersson JL, Marcus M, Nomikos GG, Svensson TH (1994) Prazosin modulates the changes in firing pattern and transmitter release induced by raclopride in the mesolimbic, but not in the nigrostriatal dopaminergic system. Naunyn Schmiedebergs Arch Pharmacol 349:236–243

    Google Scholar 

  • Ashby CR, Wang RY (1990) Effects of antipsychotic drugs on 5-HT2 receptors in the medial prefrontal cortex: microiontophoretic studies. Brain Res 506:346–348

    Google Scholar 

  • Axelson R, Nilsson A, Christensson E, Björk A (1991) Effects of amperozide in schizophrenia, Psychopharmacology 104: 287–292

    Google Scholar 

  • Bannon MJ, Reinhard JF, Bunney EB, Roth RH (1982) Unique response to antipsychotic drugs is due to absence of terminal autoreceptors in mesocortical dopamine neurons. Nature 306:791–792

    Google Scholar 

  • Bartholini G (1976) Differential effect of neuroleptic drugs on dopamine turnover in the extrapyramidal and limbic systems. J Pharm Pharmacol 28:429–433

    Google Scholar 

  • Berman KF, Weinberger DR (1990) Prefrontal dopamine and defect symptoms in schizophrenia. In: Greden JF, Tandon R (eds) Negative schizophrenic symptoms: pathophysiology and clinical implications. Progress in Psychiatry Series, vol 28, American Psychiatric Press, Washington DC, pp 81–95

    Google Scholar 

  • Bunney BS, Walters JR, Roth RH, Aghajanian GK (1973) Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. J Pharmacol Exp Ther 185:560–571

    Google Scholar 

  • Canton H, Verriele L, Colpaert FC (1990) Binding of typical and atypical antipsychotics to 5-HT1C and 5-HT2 sites: clozapine potently interacts with 5-HT1C sites. Eur J Pharmacol 191:93–96

    Google Scholar 

  • Carlsson M, Carlsson A (1990) Schizophrenia: a subcortical neurotransmitter imbalance syndrome? Schizophr Bull 16: 425–432

    Google Scholar 

  • Castelao JF, Ferreira L, Gelders YG, Heylen SLE (1989) The efficacy of the D2 and 5-HT2 antagonist risperidone (R 64 766) in the treatment of chronic psychosis. An open dose-finding study. Schizophr Res 2:411–415

    Google Scholar 

  • Chiodo LA, Bunney BS (1983) Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons. J Neurosci 3:1607–1619

    Google Scholar 

  • Chiodo LA, Bannon MJ, Grace AA, Roth RH, Bunney BS (1984) Evidence for the absence of impulse regulating somatodendritic and synthesis-modulating nerve terminal autoreceptors on sub-populations of mesocortical dopamine neurons. Neuroscience 12:1–16

    Google Scholar 

  • Claghorn J, Honigfeld G, Abuzzahab FS, Wans R, Steinbook R, Tuason V, Klerman G (1987) The risks and benefits of clozapine versus chlorpromazine, J Clin Psychopharmacol 7:377–384

    Google Scholar 

  • Deutch AY, Moghaddam B, Innis RB, Krystal JH, Aghajanian GK, Bunney BS, Charney DS (1991) Mechanisms of action of atypical antipsychotic drugs. Implications for novel therapeutic strategies for schizophrenia. Schizophr Res 4:121–156

    Google Scholar 

  • Devaud LL, Hollingsworth EB, Cooper BR (1992) Alterations in extracellular and tissue levels of biogenic amines in rat brain induced by the serotonin2 receptor antagonist, ritanserin. J Neurochem 59:1459–1466

    Google Scholar 

  • Fink H, Morgenstern R, Oetssner W (1984) Clozapine-A serotonin antagonist? Pharmacol Biochem Behav 20:513–517

    Google Scholar 

  • Gelders YG (1989) Thymosthenic agents, a novel approach in the treatment of schizophrenia. Br J Psychiatry 155:33–36

    Google Scholar 

  • Gelders Y, VandenBussche G, Reyntjens A, Janssen P (1986) Serotonin-S2 receptor blockers in the treatment of chronic schizophrenia. Clin Neuropharmacol 9:325–327

    Google Scholar 

  • Gonon FG (1988) Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry. Neuroscience 24:19–28

    Google Scholar 

  • Gonon FG, Buda M, Pujol JF (1984) Treated carbon fibre electrodes for measuring catechols and ascorbic acid. In: Marsden CA (ed) Measurement of neurotransmitter release in vivo. Wiley, Chichester, pp 153–171

    Google Scholar 

  • Grace AA, Bunney BS (1983) Intracellular and extracellular electrophysiology of nigral dopaminergic neurons. 1. Identification and characterization. Neuroscience 10:301–315

    Google Scholar 

  • Grace AA, Bunney BS (1984) The control of firing pattern in nigral dopamine neurons: burst firing. J Neurosci 4:2877–2890

    Google Scholar 

  • Grenhoff J, Ugedo L, Svensson TH (1988a) Firing patterns of midbrain dopamine neurons: differences between A9 and A10 cells. Acta Physiol Scand 134:127–132

    Google Scholar 

  • Grenhoff J, Tung C-S, Svensson TH (1988b) The excitatory amino acid antagonist kynurenate induces pacemaker-like firing of dopamine neurons in rat ventral tegmental area in vivo. Acta Physiol Scand 134:567–568

    Google Scholar 

  • Grenhoff J, Tung C-S, Ugedo L, Svensson TH (1990) Effects of amperozide, a putative antipychotic drug, on rat midbrain dopamine neurons recorded in vivo. Pharmacol Toxicol 66 [Suppl 2]:29–33

    Google Scholar 

  • Hand TH, Hu X-T, Wang RY (1987) Differential effects of acute clozapine and haloperidol on the activity of ventral tegmental (A10) and nigrostriatal (A9) dopamine neurons. Brain Res 415:257–269

    Google Scholar 

  • Högberg, T, Rämsby S, Ögren S-O, Norinder U (1987) New selective dopamine D-2 antagonists as antipsychotic agents. Pharmacological, chemical, structural and theoretical considerations. Acta Pharm Suec 24:289–328

    Google Scholar 

  • Ingvar DH (1987) Evidence for frontal/prefrontal cortical dysfunction in chronic schizophrenia: the phenomenon of hypofrontality reconsidered. In: Helmchen H, Henn FA (eds) Biological perspectives of schizophrenia Wiley, New York, pp 201–211

    Google Scholar 

  • Janssen PAJ, Niemegeers CJE, Awouters F, Schellekens KHL, Megens AAHP, Meert TF (1988) Pharmacology of risperidone (R 64 766), a new antipsychotic drug with serotonin-S2 and dopamine-D2 antagonistic properties. J Pharmacol Exp Ther 244:685–693

    Google Scholar 

  • Kalivas PW, Duffy P, Barrow J (1989) Regulation of the mesocorticolimbic dopamine system by glutamic acid receptor subtypes. J Pharmacol Exp Ther 251:378–387

    Google Scholar 

  • Kane J, Honigfeld G, Singer J, Meltzer H (1988) Clozapine for the treatment-resistant schizophrenic. Arch Gen Psychiatry 45:789–796

    CAS  PubMed  Google Scholar 

  • Kimura K, Nomikos GG, Svensson TH (1993) Effects of amperozide on psychostimulant-induced hyperlocomotion and dopamine release in the nucleus accumbens. Pharmacol Biochem Behav 44:27–36

    Google Scholar 

  • Köhler C, Hall H, Ögren S-O, Gawell L (1985) Specific in vivo and in vitro binding of 3H-raclopride. Biochem Pharmacol 34:2251–2259

    Google Scholar 

  • Korsgaard S, Gerlach J, Christensson E (1985) Behavioral aspects of serotonin-dopamine interaction in the monkey. Eur J Pharmacol 118:245–252

    Google Scholar 

  • Lappalainen J, Hieatala J, Koulu M, Syvälahti E (1990) Neurochemical effects of chronic co-administration of ritanserin and haloperidol: comparison with clozapine effects. Eur J Pharmacol 190:403–407

    Google Scholar 

  • Leysen JE (1990) Gaps and peculiarities in 5-HT2 receptor studies. Neuropsychopharmacology 3:361–369

    Google Scholar 

  • Leysen JE, Commeron W, Van Gompel P, Wynants J, Janssen PFM, Laduron PM (1985) Receptor-binding properties in vitro and in vivo of ritanserin. A very potent and long acting serotonin-S2 antagonist. Mol Pharmacol 27:600–611

    Google Scholar 

  • Liebman JM, Gerhardt SC, Gerber R (1989) Effects of 5-HT2 antagonists on haloperidol-induced dyskinesias in squirrel monkeys: no evidence for reciprocal 5-HT dopamine interaction. Psychopharmacology 97:456–461

    Google Scholar 

  • Manley ED, Kuczenski R, Segal DS, Young SJ, Groves PM (1992) Effects of frequency and pattern of medial forebrain bundle stimulation on caudate dialysate dopamine and serotonin. J Neurochem 58:1491–1498

    CAS  PubMed  Google Scholar 

  • Mantz J, Godbout R, Tassin J-P, Glowinski J, Thierry A-M (1990) Inhibition of spontaneous and evoked unit activity in the rat medial prefrontal cortex by mesencephalic raphe nuclei. Brain Res 524:22–30

    Google Scholar 

  • Meltzer HY, Nash JF (1991) Serotonin and neuropsychiatric disorders: Implications for the discovery of new psychothera peutic agents VII. Effects of antipsychotic drugs on serotonin receptors. Pharmacol Rev 43:587–604

    Google Scholar 

  • Meltzer HY, Matsubara S, Lee JC (1989) Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values. J Pharmacol Exp Ther 251:238–246

    CAS  PubMed  Google Scholar 

  • Moghaddam B, Bunney BS (1990) Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an vivo microdialysis study. J Neurochem 54:1755–1760

    CAS  PubMed  Google Scholar 

  • Murase S, Grenhoff J, Chouvet G, Gonon FG, Svensson TH (1993a) Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo. Neurosci Lett 157:53–56

    Google Scholar 

  • Murase S, Mathé JM, Grenhoff J, Svensson TH (1993b) Effects of dizocilpine (MK-801) on rat midbrain dopamine cell activity: differential actions on firing pattern related to anatomical localization. J Neural Transm Gen Sect 91:13–25

    Google Scholar 

  • Nishino H, Ono T, Muramoto K, Fukuda M, Sasaki K (1987) Neuronal activity in the ventral tegmental area (VTA) during motivated bar press feeding in the monkey. Brain Res 413:302–313

    Google Scholar 

  • Nomikos GG, Damsma G, Wenkstern D, Fibiger HC (1989) Acute effects of bupropion on extracellular dopamine concentrations in rat striatum and nucleus accumbens studied by in vivo microdialysis. Neuropsychopharmacology 2:273–281

    Google Scholar 

  • Nomikos GG, Damsma G, Wenkstern D, Fibiger HC (1992) Effects on chronic bupropion on interstitial concentrations of dopamine in rat nucleus accumbens and striatum. Neuropsychopharmacology 7:7–14

    Google Scholar 

  • Nomikos GG, Iurlo M, Andersson JL, Kimura K, Svensson TH (1994) Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex. Psychopharmacology 115:147–156

    Google Scholar 

  • North RA, Uchimura N (1989) 5-hydroxytryptamine acts at 5-HT2 receptors to decrease potassium conductance in rat nucleus accumbens neurons. J Physiol (Lond) 417:1–12

    Google Scholar 

  • Palacios JM, Waeber C, Mengod G, Hoyer D (1991) Autoradiography of 5-HT receptors: a critical appraisal. Neurochem Int 18:17–25

    Google Scholar 

  • Paxinos G, Watson C (1986) The rat brain in stereotaxix coordinates, 2nd edn. Academic Press, London

    Google Scholar 

  • Pazos A, Cortés R, Palacios JM (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors. Brain Res 346:231–249

    Google Scholar 

  • Roth BL, Ciaranello RD, Meltzer HY (1992) Binding of typical and atypical antipsychotic agents to transiently expressed 5-HT1C receptors. J Pharmacol Exp Ther 260:1361–1365

    Google Scholar 

  • Saller CH, Czupryna MJ, Salama AI (1990) 5-HT Z receptor blockade by ICI 169, 369 and other 5-HT2 antagonists modulates the effects of D-2 dopamine receptor blockade. J Pharmacol Exp Ther 223:65–74

    Google Scholar 

  • Schmidt WJ (1986) Intrastriatal injection of DL-2-amino-5-phosphonovaleric acid (AP-5) induces sniffing stereotypy that is antagonized by haloperidol and clozapine. Psychopharmacology 90:123–130

    Google Scholar 

  • Schmidt CJ, Fadayel GM, Sullivan CK, Taylor VL (1992) 5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100, 907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine. Eur J Pharmacol 223:65–74

    Google Scholar 

  • Schotte A, de Bruyckere K, Janssen PFM, Leysen JL (1989) Receptor occupancy by ritanserin and risperidone measured using ex vivo autoradiography. Brain Res 500:295–301

    Google Scholar 

  • Schultz W, Apicella P, Ljungberg (1993) Responses of monkey dopamine neurons to reward and conditioned stimuli during successive steps of learning a delayed response task. J Neurosci 13:900–913

    Google Scholar 

  • Suaud-Chagny MF, Chergui K, Chouvet G, Gonon FG (1992) Relationship between dopamine release in the rat nucleus accumbens and the discharge activity of dopaminergic neurons during local in vivo application of amino acids in the ventral tegmental area. Neuroscience 49:63–72

    Google Scholar 

  • Svartengren J, Celander M (1994) The limbic functional selectivity of amperozide is not mediated by dopamine D2 receptors as assessed by in vitro and in vivo binding. Eur J Pharmacol 254:73–81

    Google Scholar 

  • Svartengren J, Simonsson P (1990) Receptor binding properties of amperozide, Pharmacol Toxicol 66 [Suppl 1]:8–11

    Google Scholar 

  • Svensson TH, Tung C-S (1989) Local cooling of prefrontal cortex induces pacemaker-like firing of dopamine neurons in rat ventral tegmental are in vivo. Acta Physiol Scand 136:135–136

    Google Scholar 

  • Svensson TH, Tung C-S, Grenhoff J (1989) The 5-HT 2 antagonist ritanserin blocks the effect of pre-frontal cortex inactivation on rat A10 dopamine neurons in vivo. Acta Physiol Scand 136:497–498

    Google Scholar 

  • Tarazi FI, Shirakawa O, Tamminga CA (1993) Low dose of raclopride spares the extrapyramidal system in rat brain from metabolic effects. Eur J Pharmacol 232:71–77

    Google Scholar 

  • Ugedo L, Grenhoff J, Svensson TH (1989) Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition. Psychopharmacology 98:45–50

    Google Scholar 

  • Wadenberg M-L (1992) Antagonism by 8-OH-DPAT, but not ritanserin, of catalepsy induced by SCH 23390 in the rat. J Neural Transm Gen Sect 89:49–59

    Google Scholar 

  • Wang RY (1981) Dopaminergic neurons in the rat ventral tegmental area. I. Identification and characterization. Brain Res Brain Res Rev 3:123–140

    Google Scholar 

  • Weinberger DR (1987) Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44:660–669

    Google Scholar 

  • Werner G, Mountcastle VB (1963) The variability of central neural activity in a sensory system, and its implications for the central reflection of sensory effects. J Neurophysiol 26:958–977

    Google Scholar 

  • White FJ, Wang RY (1983) Differential effect of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons. Science 221:1054–1055

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Physiology and Pharmacology, Division of Pharmacology, Karolinska Institute, S-17177, Stockholm, Sweden

    J. L. Andersson, G. G. Nomikos, M. Marcus, P. Hertel, J. M. Mathe & T. H. Svensson

Authors
  1. J. L. Andersson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. G. Nomikos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Marcus
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. Hertel
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. M. Mathe
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. T. H. Svensson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Andersson, J.L., Nomikos, G.G., Marcus, M. et al. Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectively in the mesolimbic dopaminergic system. Naunyn-Schmiedeberg's Arch Pharmacol 352, 374–385 (1995). https://doi.org/10.1007/BF00172774

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00172774

Key words

Search

Navigation